Thermo Fisher presents diagnostic solutions at ADLM 2026
The press release highlights FDA clearances for EXENT multiple myeloma test and EliA CTD 13 screen, plus LabLink360 software.
See the latest news and media coverage for Thermo Fisher. We track all announcements, press releases, and industry mentions in real time, all in one place.
Life sciences technology and services company
thermofisher.comLast updated
In short: Thermo Fisher raised its 2026 revenue forecast following strong Q2 growth and high demand for instruments from biotech and pharma clients.
The press release highlights FDA clearances for EXENT multiple myeloma test and EliA CTD 13 screen, plus LabLink360 software.
The media-on-demand workflow simplifies media preparation and supports traceable enrichment testing.
Revenue reached $11.99B with adjusted EPS of $6.03, reflecting strong end market demand and new product launches.
The approval enables Rapid DNA profiles to be searched in the national CODIS database, accelerating investigations.
The company reported Q2 results above expectations and increased its full-year outlook, citing stronger customer activity.
Thermo Fisher Scientific Inc. raised its revenue forecast after stronger-than-expected spending by biotech and pharma customers and a rebound in laboratory instrument demand helped pushed...
Thermo Fisher Scientific Inc. (NYSE:TMO) saw its share prices increase by 8.71 percent on Thursday to close at $572.32 apiece, as investors took heart from...
ImmuPharma PLC (AIM:IMM, FRA:25I), the drug discovery company, has appointed Thermo Fisher Scientific to develop and manufacture the finished form of its experimental diabetes treatment...
Track Thermo Fisher and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Thermo Fisher and other trending companies.